801 On Other Exchanges
Symbol
Exchange
801 is not on other exchanges.

golden meditech holdings ltd (801) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GOLDEN MEDITECH HOLDINGS LTD (801)

Related News

No related news articles were found.

golden meditech holdings ltd (801) Related Businessweek News

No Related Businessweek News Found

golden meditech holdings ltd (801) Details

Golden Meditech Holdings Limited, an investment holding company, operates as an integrated healthcare enterprise in the People’s Republic of China. It operates through five segments: Medical Devices, Hospital Management, Medical Insurance Administration, Chinese Herbal Medicines, and Cord Blood Storage. The Medical Devices segment develops, manufactures, and sells medical devices and medical accessories. This segment also offers blood related medical devices, such as Autologous Blood Recovery System and its consumables. The Hospital Management segment offers hospital management services; and operates two hospitals in Beijing and Shanghai that specializes in haematology and a range of medical disciplines. The Medical Insurance Administration segment provides medical insurance administration services. This segment also provides claim processing and bill settlement services to medical insurance companies, hospitals, and policy holders. The Chinese Herbal Medicine segment is involved in the research, development, manufacture, and sale of Chinese herbal medicines. The Cord Blood Bank segment provides cord blood stem cell examination, processing, separation, storage, and other related services. The company was formerly known as Golden Meditech Company Limited and changed its name to Golden Meditech Holdings Limited in March 2010. Golden Meditech Holdings Limited was incorporated in 2001 and is headquartered in Beijing, the People’s Republic of China.

738 Employees
Last Reported Date: 11/23/16
Founded in 2001

golden meditech holdings ltd (801) Top Compensated Officers

Founder, Chairman, Chief Executive Officer an...
Total Annual Compensation: $13.5M
Company Secretary and Executive Director
Total Annual Compensation: $12.0M
Consultant
Total Annual Compensation: $555.0K
Compensation as of Fiscal Year 2016.
golden meditech holdings ltd
Golden Meditech Holdings Limited, Special/Extraordinary Shareholders Meeting, Jan 16, 2017

Golden Meditech Holdings Limited, Special/Extraordinary Shareholders Meeting, Jan 16, 2017, at 10:00 China Standard Time. Location: No.4 Yong Chang North Road Beijing Economic Technological Development Area Beijing China Agenda: to consider and discuss on Settlement Agreement A, Settlement Agreement B.

Golden Meditech Holdings Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended September 30, 2016

Golden Meditech Holdings Limited reported unaudited consolidated earnings results for the six months ended September 30, 2016. For the period, the company reported revenue from continuing operations of HKD 121,672,000 compared to HKD 150,527,000 a year ago. Loss from operations was HKD 162,014,000 compared to HKD 116,621,000 a year ago. Loss before taxation was HKD 325,548,000 compared to HKD 146,271,000 a year ago. Loss for the period from continuing operations was HKD 329,428,000 compared to HKD 150,813,000 a year ago. Loss for the period was HKD 193,947,000 compared to HKD 380,153,000 a year ago. Loss attributable to the company's equity shareholders from continuing operations was HKD 317,154,000 or 10.69 cents per basic share compared to HKD 138,275,000 or 7.36 cents per basic share a year ago. Net cash generated from investing activities was HKD 246,291,000 compared to HKD 49,267,000 a year ago. Payment for purchase of property, plant and equipment was HKD 44,183,000 compared to HKD 85,637,000 a year ago. Loss before interest, tax, depreciation and amortisation, fair value changes in financial assets and financial liabilities was HKD 113,082,000 compared to HKD 74,132,000 a year ago. Adjusted loss attributable to the company's equity shareholders was HKD 166,752,000 or 5.62 cents per basic share compared to HKD 138,275,000 or 7.36 cents per basic share a year ago.

Golden Meditech Holdings Limited to Report First Half, 2017 Results on Nov 23, 2016

Golden Meditech Holdings Limited announced that they will report first half, 2017 results on Nov 23, 2016

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

801 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 801.
View Industry Companies
 

Industry Analysis

801

Industry Average

Valuation 801 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.7x
Price/Book 1.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GOLDEN MEDITECH HOLDINGS LTD, please visit www.goldenmeditech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.